1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsYoung Investigator Award Special Competitions is sponsored by Conquer Cancer, the ASCO Foundation. Special competitions under the Young Investigator Award program, providing funding for early-career physicians to conduct mentored research in clinical oncology.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Conquer Cancer Foundation -- Young Investigator Awards (YIA) | Research Funding American Society of Clinical Oncology Conquer Cancer Foundation -- Young Investigator Awards (YIA) The Conquer Cancer Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology.
The purpose of these grants is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Applications in the applicable areas of cancer research are accepted from U.S. and international applicants.
The YIA is a one-year grant totaling $50,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants & Awards Ceremony at the ASCO Annual Meeting. Applicants who are selected to receive a YIA are allowed to receive grants from other funding sources as long as there is no scientific or budgetary overlap. The number of YIA grants available for a special competition will be noted in each RFP.
Areas with Endowed and Dedicated Funding (as of July 1, 2025) Conquer Cancer has endowed and multi-year funding for certain areas that allows us to fund grants in these areas year after year. For 2026, dedicated funding is available in, but not limited to, the areas listed below. This list will be updated as new funding is confirmed.
Young Investigator Award in Drug Development ( Request for Proposals - due January 29, 2026) Young Investigator Award in Survivorship ( Request for Proposals - due January 29, 2026) Young Investigator Award in Supportive Care ( Request for Proposals - due January 29, 2026) Young Investigator Award in Geriatric Oncology ( Request for Proposals - due January 29, 2026) Young Investigator Award in Primary Brain Tumors ( Request for Proposals - due January 29, 2026) Young Investigator Award for Veteran Cancer ( Request for Proposals - due March 12, 2026) Young Investigator Award in Mantle Cell Lymphoma ( Request for Proposals - due March 12, 2026) Young Investigator Award in Chronic Lymphocytic Leukemia ( Request for Proposals - due March 12, 2026) Applicants may only submit one YIA application either under a special competition or the general competition.
Applicants must meet the following criteria: Be a physician (MD, DO, or international equivalent) working in any country. An MD, PhD is eligible if both degrees are completed prior to the start of the grant period. Be within the last two years of their final oncology subspecialty training or fellowship program at an academic medical institution at the time of application submission.
Examples of a subspecialty training include, but are not limited to, a hematology-oncology fellowship, a surgical oncology fellowship, or a radiation oncology residency.
An exception to this window may be granted under the following circumstances: Applicants in training programs where the protected research time or dedicated research year may occur during the first year of the training program or outside the last two years of training (ex: In surgical oncology fellowship programs, the dedicated research year may occur during the first year of the program).
Applicants who completed their subspecialty training within three months of the application deadline. If you think that you may be eligible for an exception, please contact grants@conquer. org with your CV.
Be within 10 years of obtaining their medical degree at the time of application submission. An exception to this criterion may be granted to foreign medical graduates whose medical degree completion may fall outside of the 10-year cutoff. Please see the FAQ for more information or contact grants@conquer.
org . Be planning an investigative career in oncology. Have a valid, active medical license in the country where the research will be conducted at the time of application.
Be working in an oncology laboratory or clinical research setting. Have a mentor from the sponsoring institution. If the mentor is not an ASCO member, a supporting letter from an ASCO member from the sponsoring institution must be included.
Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, visit asco. org/membership .
Be able to commit at least 60% of their time for research (applies to total effort, not just the proposed YIA project) during the award period. Medical - Clinical Science
According to the current listing, eligibility includes: Physicians (MD, DO, or equivalent) within two years of completing oncology subspecialty training or in their first year of full-time academic faculty appointment. Confirm the full requirements in the official notice before applying.
The current listing shows $50,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Young Investigator Award Special Competitions are due March 12, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Young Investigator Award Special Competitions is funded by Conquer Cancer, the ASCO Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article